CLINICAL_TRIALS
trial_result
· 2022-06-24
Clinical Trial Update: Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes [Phase 3]
Summary
A health economic analysis related to islet cell transplantation for stabilizing severe Type 1 Diabetes in a Phase 3 study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Grenoble | Conditions: Type 1 Diabetes | Phase 3 | Status: UNKNOWN